FOLH1 and posterior cortical atrophy: As a result, PSMA has become one of the best candidates for PET imaging of PCa, and recently peptidomimetic PSMA inhibitors based on the scaffolds: Glu-CO-Glu-OH and Lys-CO-Glu have demonstrated outstanding performance as radioligands for PET diagnostic imaging (68Ga-PSMA-11) and PCa treatment (177Lu-PSMA-617) (18).